This was reported by The Hill newspaper with reference to data published by the US Food and Drug Administration (FDA).

According to published information, the vaccine can be up to 85% effective in treating the most severe cases of the disease.

As the newspaper writes, the FDA expert council on Friday, February 26, will hold a meeting at which a decision will be made on the advisability of approving this drug.

It is clarified that in case of a positive decision, the vaccine from Johnson & Johnson may be approved for use in the United States this week.

The American company Johnson & Johnson has filed an application with the World Health Organization (WHO) for the registration of a vaccine against the coronavirus of the Belgian pharmacological division Janssen.